Kerri St. Denis

4.5k total citations · 3 hit papers
18 papers, 1.9k citations indexed

About

Kerri St. Denis is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Kerri St. Denis has authored 18 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 4 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Kerri St. Denis's work include SARS-CoV-2 and COVID-19 Research (17 papers), Viral gastroenteritis research and epidemiology (6 papers) and COVID-19 Clinical Research Studies (5 papers). Kerri St. Denis is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (17 papers), Viral gastroenteritis research and epidemiology (6 papers) and COVID-19 Clinical Research Studies (5 papers). Kerri St. Denis collaborates with scholars based in United States, South Africa and Germany. Kerri St. Denis's co-authors include Alejandro B. Balazs, Evan C. Lam, Wilfredo F. García-Beltrán, Vivek Naranbhai, A. John Iafrate, Blake M. Hauser, Aaron G. Schmidt, Jared Feldman, David J. Gregory and Adam D. Nitido and has published in prestigious journals such as Cell, Nature Communications and Clinical Infectious Diseases.

In The Last Decade

Kerri St. Denis

18 papers receiving 1.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

2021 849 citations Wilfredo F. García-Beltrán, Evan C. Lam et al. Cell profile →
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

2022 651 citations Wilfredo F. García-Beltrán, Kerri St. Denis et al. Cell profile →
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals

2022 157 citations Vivek Naranbhai, Anusha Nathan et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kerri St. Denis United States	12	1.7k	486	291	233	218	18	1.9k
Evan C. Lam United States	14	2.1k 1.2×	558 1.1×	351 1.2×	277 1.2×	235 1.1×	23	2.4k
Jared Feldman United States	13	2.2k 1.3×	702 1.4×	419 1.4×	299 1.3×	205 0.9×	24	2.6k
Frauke Muecksch United States	12	1.3k 0.8×	322 0.7×	198 0.7×	151 0.6×	145 0.7×	20	1.5k
Amy Kempf Germany	12	1.5k 0.9×	380 0.8×	160 0.5×	206 0.9×	94 0.4×	27	1.6k
Luise Graichen Germany	10	1.4k 0.8×	356 0.7×	146 0.5×	210 0.9×	94 0.4×	21	1.6k
Daniel Marrama United States	6	2.0k 1.2×	465 1.0×	537 1.8×	138 0.6×	133 0.6×	6	2.3k
Aaron Sutherland United States	8	2.0k 1.2×	467 1.0×	545 1.9×	137 0.6×	136 0.6×	14	2.4k
C Tham Singapore	12	1.7k 1.0×	409 0.8×	501 1.7×	136 0.6×	128 0.6×	18	2.1k
Carolyn Rydyznski Moderbacher United States	5	2.5k 1.4×	581 1.2×	695 2.4×	184 0.8×	188 0.9×	5	2.8k

Countries citing papers authored by Kerri St. Denis

Since Specialization

Citations

This map shows the geographic impact of Kerri St. Denis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerri St. Denis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerri St. Denis more than expected).

Fields of papers citing papers by Kerri St. Denis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerri St. Denis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerri St. Denis. The network helps show where Kerri St. Denis may publish in the future.

Co-authorship network of co-authors of Kerri St. Denis

This figure shows the co-authorship network connecting the top 25 collaborators of Kerri St. Denis. A scholar is included among the top collaborators of Kerri St. Denis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerri St. Denis. Kerri St. Denis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wamhoff, Eike‐Christian, Larance Ronsard, Jared Feldman, et al.. (2024). Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds. Nature Communications. 15(1). 795–795. 40 indexed citations

Roederer, Alex, Kerri St. Denis, Maegan L. Sheehan, et al.. (2024). Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity. Cell Reports Medicine. 5(12). 101850–101850. 1 indexed citations

Bartsch, Yannic C., Kerri St. Denis, Paulina Kapłonek, et al.. (2022). SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children. Science Translational Medicine. 14(672). eabn9237–eabn9237. 31 indexed citations

Hauser, Blake M., Jared Feldman, Maya Sangesland, et al.. (2022). Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design. Cell Reports Medicine. 3(12). 100834–100834. 4 indexed citations

Hauser, Blake M., Maya Sangesland, Kerri St. Denis, et al.. (2022). Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting. Cell Reports. 38(12). 110561–110561. 15 indexed citations

Naranbhai, Vivek, Anusha Nathan, Clarety Kaseke, et al.. (2022). T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell. 185(6). 1041–1051.e6. 157 indexed citations breakdown →

García-Beltrán, Wilfredo F., Kerri St. Denis, Angelique Hœlzemer, et al.. (2022). mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. Cell. 185(3). 457–466.e4. 651 indexed citations breakdown →

Bartsch, Yannic C., Jaewon Kang, Madeleine D. Burns, et al.. (2022). BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children. npj Vaccines. 7(1). 158–158. 9 indexed citations

Canaday, David H., Oladayo A. Oyebanji, Elizabeth M. White, et al.. (2022). COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents. EBioMedicine. 80. 104066–104066. 28 indexed citations

10.

Burns, Madeleine D., Brittany P. Boribong, Yannic C. Bartsch, et al.. (2022). Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children. Vaccines. 10(4). 492–492. 9 indexed citations

11.

Canaday, David H., Lenore L. Carias, Oladayo A. Oyebanji, et al.. (2021). Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents. Clinical Infectious Diseases. 73(11). 2112–2115. 56 indexed citations

12.

Canaday, David H., Oladayo A. Oyebanji, Michael Payne, et al.. (2021). Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination. Clinical Infectious Diseases. 75(1). e884–e887. 23 indexed citations

13.

Feldman, Jared, Julia Bals, Clara G. Altomare, et al.. (2021). Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses. Science Immunology. 6(66). eabl5842–eabl5842. 28 indexed citations

14.

Naranbhai, Vivek, Kerri St. Denis, Evan C. Lam, et al.. (2021). Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy. Radiotherapy and Oncology. 166. 88–91. 9 indexed citations

15.

García-Beltrán, Wilfredo F., Kerri St. Denis, Angelique Hœlzemer, et al.. (2021). mRNA-Based COVID-19 Vaccine Boosters Induce Neutralizing Immunity Against SARS-CoV-2 Omicron Variant. SSRN Electronic Journal. 13 indexed citations

16.

Oyebanji, Oladayo A., Brigid Wilson, Lenore L. Carias, et al.. (2021). Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?. Aging Clinical and Experimental Research. 33(11). 3151–3160. 14 indexed citations

17.

García-Beltrán, Wilfredo F., Evan C. Lam, Kerri St. Denis, et al.. (2021). Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 184(9). 2372–2383.e9. 849 indexed citations breakdown →

18.

Hauser, Blake M., Maya Sangesland, Kerri St. Denis, et al.. (2021). Rationally Designed Immunogens Enable Immune Focusing Following SARS-CoV-2 Spike Imprinting. SSRN Electronic Journal. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact